secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001193125-24-159143
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences directors Koppel and Shah resign; shareholders approve doubling authorized shares to 120M
--------------------------------------------------------------------------------

- Adam Koppel and Rajeev Shah resigned from the Board effective June 11, 2024; no disagreement cited.
- Shareholders approved increase of authorized common stock from 60M to 120M shares.
- Equity incentive plan amended to add 2M shares; total available for issuance increased accordingly.
- Four Class III directors elected: Martin Freed, Ilan Ganot, Georgia Keresty, Ian Smith.
- Advisory vote on executive compensation held every year; PricewaterhouseCoopers ratified as auditor for FY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/0001193125-24-159143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/d845618d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-159143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer